Medicare Enrolled

Dr. Paul Szwejbka, M.D., M.P.H.

Neurology · Fayetteville, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
4140 FERNCREEK DR, Fayetteville, NC 28314
9103230179
Registered in NPPES since 2005
NPI: 1366447757 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Szwejbka from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Szwejbka? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Szwejbka

Dr. Paul Szwejbka is a neurology specialist in Fayetteville, NC, with 21 years of NPI registration. Based on federal Medicare data, Dr. Szwejbka performed 1,128 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Szwejbka received a total of $8,161 from 57 pharmaceutical and/or device companies across 410 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Szwejbka is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 17% volume in NC $8,161 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,128
Medicare services
Top 17% in NC for neurology
Not available
Unique patients (not deduplicated)
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
351 $82 $341
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
258 $121 $469
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
232 $72 $272
New patient office visit, complex (60-74 min) 69 $151 $608
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
58 $92 $600
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
57 $159 $1,050
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
54 $59 $242
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
49 $131 $840
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
5.1% high complexity
0.0% medium
94.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,161
Total received (2018-2024)
Avg $1,166/year across 7 years
Top 24% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
410
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,632
2023
$1,446
2022
$431
2021
$417
2020
$329
2019
$1,250
2018
$2,655

Payments by company (2024)

TG Therapeutics, Inc.
$349
Biogen, Inc.
$271
Alexion Pharmaceuticals, Inc.
$200
Eisai Inc.
$161
Lundbeck LLC
$102
EMD Serono, Inc.
$92
ARGENX US, INC.
$63
Celgene Corporation
$45
Amneal Pharmaceuticals LLC
$41
Lilly USA, LLC
$41
UCB, Inc.
$39
Genentech USA, Inc.
$33
Novartis Pharmaceuticals Corporation
$30
Neurocrine Biosciences, Inc.
$29
Otsuka Pharmaceutical Development & Commercialization, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$18
Amgen Inc.
$17
Neurelis, Inc.
$16
CSL Behring
$14
SK Life Science, Inc.
$14
Abbott Laboratories
$14
PFIZER INC.
$13
Aucta Pharmaceuticals, Inc.
$12
Top 3 companies account for 50.2% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,177
Alexion Pharmaceuticals, Inc.
$594
UCB, Inc.
$590
Eisai Inc.
$371
TG Therapeutics, Inc.
$349
Amgen Inc.
$336
Sunovion Pharmaceuticals Inc.
$285
Teva Pharmaceuticals USA, Inc.
$281
Novartis Pharmaceuticals Corporation
$281
Otsuka America Pharmaceutical, Inc.
$276
EMD Serono, Inc.
$253
Genentech USA, Inc.
$225
GENZYME CORPORATION
$211
Avanir Pharmaceuticals, Inc.
$194
ACADIA Pharmaceuticals Inc
$191
TG THERAPEUTICS, INC.
$189
Lundbeck LLC
$181
LivaNova USA, Inc.
$152
Acorda Therapeutics, Inc
$149
Medtronic Vascular, Inc.
$124
ARBOR PHARMACEUTICALS, INC.
$114
Supernus Pharmaceuticals, Inc.
$106
Celgene Corporation
$104
Assertio Therapeutics, Inc.
$102
SK Life Science, Inc.
$102
Grifols USA, LLC
$95
Neurocrine Biosciences, Inc.
$79
ARGENX US, INC.
$78
Adamas Pharmaceuticals, Inc.
$76
Lilly USA, LLC
$72
CSL Behring
$67
Amneal Pharmaceuticals LLC
$65
Corium, LLC
$62
PFIZER INC.
$56
Sumitomo Pharma America, Inc.
$52
Allergan Inc.
$47
US WorldMeds, LLC
$47
Greenwich Biosciences, Inc.
$41
Merz North America, Inc.
$37
Neurelis, Inc.
$36
AbbVie Inc.
$31
Kyowa Kirin, Inc.
$29
Impax Laboratories, Inc.
$26
JAZZ PHARMACEUTICALS INC.
$22
Mitsubishi Tanabe Pharma America, Inc.
$22
Otsuka Pharmaceutical Development & Commercialization, Inc.
$20
Avion Pharmaceuticals
$18
E.R. Squibb & Sons, L.L.C.
$18
GE Healthcare
$16
ABBVIE INC.
$16
GE HEALTHCARE
$15
EISAI INC.
$15
ASSERTIO THERAPEUTICS, Inc.
$14
Abbott Laboratories
$14
Bausch Health US, LLC
$13
Mylan Pharmaceuticals Inc.
$12
Aucta Pharmaceuticals, Inc.
$12
Top 3 companies account for 28.9% of all-time payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · Cambia · Dhivy · EMGALITY · EPIDIOLEX · Epidiolex · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PAXLOVID · QULIPTA · REXULTI · RYTARY · Radicava · Rebif · Reveal LINQ · Rystiggo · SOLIRIS · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XEOMIN · Xadago · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Fayetteville?
Compare neurologists in the Fayetteville area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
27
County median income
$58,780
Nearest hospital to ZIP centroid (approximate)
Womack AMC (FT Bragg)
5.2 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Szwejbka is a clinical cardiology specialist, with above-average Medicare volume (top 17% in NC), with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Szwejbka experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Szwejbka performed 351 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Szwejbka receive payments from pharmaceutical companies?
Yes. Dr. Szwejbka received a total of $8,161 from 57 companies across 410 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Szwejbka's costs compare to other neurologists in Fayetteville?
Dr. Szwejbka's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Szwejbka) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →